Inovio Pharmaceuticals Inc (NASDAQ: INO) kicked off on Tuesday, up 4.62% from the previous trading day, before settling in for the closing price of $1.95. Over the past 52 weeks, INO has traded in a range of $1.30-$7.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 22.92%. While this was happening, its average annual earnings per share was recorded 52.78%. With a float of $52.72 million, this company’s outstanding shares have now reached $53.14 million.
Inovio Pharmaceuticals Inc (INO) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Inovio Pharmaceuticals Inc is 0.79%, while institutional ownership is 19.15%.
Inovio Pharmaceuticals Inc (INO) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.89 earnings per share (EPS), higher than consensus estimate (set at -1.13) by 0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 52.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.83% during the next five years compared to 22.92% growth over the previous five years of trading.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Trading Performance Indicators
Take a look at Inovio Pharmaceuticals Inc’s (INO) current performance indicators. Last quarter, stock had a quick ratio of 1.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 602.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.61, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.51 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc (INO)
Looking closely at Inovio Pharmaceuticals Inc (NASDAQ: INO), its last 5-days average volume was 1.48 million, which is a jump from its year-to-date volume of 1.23 million. As of the previous 9 days, the stock’s Stochastic %D was 84.02%.
During the past 100 days, Inovio Pharmaceuticals Inc’s (INO) raw stochastic average was set at 71.15%, which indicates a significant decrease from 94.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1300 in the past 14 days, which was higher than the 0.1200 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6600, while its 200-day Moving Average is $2.2000. However, in the short run, Inovio Pharmaceuticals Inc’s stock first resistance to watch stands at $2.0700. Second resistance stands at $2.1100. The third major resistance level sits at $2.1700. If the price goes on to break the first support level at $1.9800, it is likely to go to the next support level at $1.9200. Now, if the price goes above the second support level, the third support stands at $1.8800.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Key Stats
The company with the Market Capitalisation of 108.41 million has total of 53,143K Shares Outstanding. Its annual sales at the moment are 220 K in contrast with the sum of -107,250 K annual income. Company’s last quarter sales were recorded 70 K and last quarter income was -19,690 K.
